APA

Jackson W. C., Suresh K., Maurino C., Feng M., Cuneo K. C., Ten Haken R. K., Lawrence T. S., Schipper M. J. & Owen D. (20200601). A mid-treatment break and reassessment maintains tumor control and reduces toxicity in patients with hepatocellular carcinoma treated with stereotactic body radiation therapy. : Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Chicago

Jackson W C, Suresh K, Maurino C, Feng M, Cuneo K C, Ten Haken R K, Lawrence T S, Schipper M J and Owen D. 20200601. A mid-treatment break and reassessment maintains tumor control and reduces toxicity in patients with hepatocellular carcinoma treated with stereotactic body radiation therapy. : Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Harvard

Jackson W. C., Suresh K., Maurino C., Feng M., Cuneo K. C., Ten Haken R. K., Lawrence T. S., Schipper M. J. and Owen D. (20200601). A mid-treatment break and reassessment maintains tumor control and reduces toxicity in patients with hepatocellular carcinoma treated with stereotactic body radiation therapy. : Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

MLA

Jackson W C, Suresh K, Maurino C, Feng M, Cuneo K C, Ten Haken R K, Lawrence T S, Schipper M J and Owen D. A mid-treatment break and reassessment maintains tumor control and reduces toxicity in patients with hepatocellular carcinoma treated with stereotactic body radiation therapy. : Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 20200601.